These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor. Poirot SS, Escrieut C, Dufresne M, Martinez J, Bouisson M, Vaysse N, Fourmy D. Mol Pharmacol; 1994 Apr; 45(4):599-607. PubMed ID: 8183238 [Abstract] [Full Text] [Related]
24. Combinatorial solid phase synthesis of multiply substituted 1,4-benzodiazepines and affinity studies on the CCK2 receptor (part 1). Lattmann E, Billington DC, Poyner DR, Arayarat P, Howitt SB, Lawrence S, Offel M. Drug Des Discov; 2002 Apr; 18(1):9-21. PubMed ID: 12375632 [Abstract] [Full Text] [Related]
25. Competitive displacement binding assay on rat brain sections and using a beta-imager: application to mu-opioid ligands. Poisnel G, Quentin T, Barré L, Coquerel A, Debruyne D. J Neurosci Methods; 2006 Jun 30; 154(1-2):60-7. PubMed ID: 16423409 [Abstract] [Full Text] [Related]
26. Cloning, heterologous expression and pharmacological characterization of a kappa opioid receptor from the brain of the rough-skinned newt, Taricha granulosa. Bradford CS, Walthers EA, Searcy BT, Moore FL. J Mol Endocrinol; 2005 Jun 30; 34(3):809-23. PubMed ID: 15956349 [Abstract] [Full Text] [Related]
27. Delta and mu opioid receptors from the brain of a urodele amphibian, the rough-skinned newt Taricha granulosa: cloning, heterologous expression, and pharmacological characterization. Bradford CS, Walthers EA, Stanley DJ, Baugh MM, Moore FL. Gen Comp Endocrinol; 2006 May 01; 146(3):275-90. PubMed ID: 16375901 [Abstract] [Full Text] [Related]
28. Differential coupling of mu-, delta-, and kappa-opioid receptors to G alpha16-mediated stimulation of phospholipase C. Lee JW, Joshi S, Chan JS, Wong YH. J Neurochem; 1998 May 01; 70(5):2203-11. PubMed ID: 9572309 [Abstract] [Full Text] [Related]
29. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles. Ioja E, Tourwé D, Kertész I, Tóth G, Borsodi A, Benyhe S. Brain Res Bull; 2007 Sep 14; 74(1-3):119-29. PubMed ID: 17683797 [Abstract] [Full Text] [Related]
33. Design, synthesis, and biological activities of cyclic lactam peptide analogues of dynorphine A(1-11)-NH2. Lung FD, Collins N, Stropova D, Davis P, Yamamura HI, Porreca F, Hruby VJ. J Med Chem; 1996 Mar 01; 39(5):1136-41. PubMed ID: 8676350 [Abstract] [Full Text] [Related]
34. New benzomorphan derivatives of MPCB as MOP and KOP receptor ligands. Pasquinucci L, Iadanza M, Marrazzo A, Prezzavento O, Ronsisvalle S, Scoto GM, Parenti C, De Luca L, Ronsisvalle G. Pharmazie; 2007 Nov 01; 62(11):813-24. PubMed ID: 18065096 [Abstract] [Full Text] [Related]
36. Biochemical and pharmacological profiles of loxiglumide, a novel cholecystokinin-A receptor antagonist. Fukamizu Y, Nakajima T, Kimura K, Kanda H, Fujii M, Saito T, Kasai H. Arzneimittelforschung; 1998 Jan 01; 48(1):58-64. PubMed ID: 9522034 [Abstract] [Full Text] [Related]
37. Direct measurements of in situ interactions of rat brain opioid receptors with the guanine nucleotide-binding protein Go. Georgoussi Z, Carr C, Milligan G. Mol Pharmacol; 1993 Jul 01; 44(1):62-9. PubMed ID: 8393523 [Abstract] [Full Text] [Related]